The Chilled Plus Program: Helping Adolescents with Anxiety and Depression.

Not Applicable

Completed

• Conditions: Anxiety; Depression; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12616000139471
• Lead Sponsor: Dr Carolyn Schniering

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02-05
• Study Completion: 2017-04-30
• Last Update Posted: 9 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 91

Inclusion Criteria

1. Participants must meet DSM-5 criteria for both an anxiety disorder and a depressive disorder.
2. Gender: male and female
3. Age range: 12-17 years
4. Willingness to provide informed consent and willingness to participate and comply with the study requirements.

Exclusion Criteria

1. Participants who are at current risk for suicide.
2. Participants who are actively self-harming
3. Participants with unmanaged psychotic symptoms
4. Participants in physically/sexually abusive environments.
5. Participants receiving pharmacological treatment who are not willing to keep medication stable throughout the duration of the study.
6. Participants with bipolar depression.
7. Participants who cannot speak english.
8. Participants with no access to the internet.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of diagnoses as measured by the Anxiety Disorders Interview Schedule for Children (ADIS-C; Silverman & Albano, 1996) according to DSM-5 criteria. [Diagnostic interviews will be conducted prior to group allocation, following the 8 week waiting period for the wait list group, immediately following treatment and three months following treatment. ];Severity of diagnoses as measured by the Anxiety Disorders Interview Schedule for Children (ADIS-C; Silverman & Albano, 1996) according to DSM-5 criteria. [Diagnostic interviews will be conducted prior to group allocation, following the 8 week waiting period for the wait list group, immediately following treatment and three months following treatment. ]